摘要
背景:在这个工业化的世界,15%的夫妻遭受了不孕不育的问题。与此相应,任何可能由治疗不孕不育症导致的潜在终身患病率引起了对公众健康的极大关注。不孕不育药物的作用,虽然主要是有关于他们通过对经典的调控荷尔蒙的靶组织(包括性轴,即子宫,卵巢和乳房)的可能影响(掩盖一些再生产荷尔蒙的受体),但是也可能对其他的器官有影响。当对一个人的不孕不育治疗影响到达恶性肿瘤出现的条件时,毫无疑问的是肿瘤在那些遭受不孕不育或者正在治疗不育不孕的女性身上,倾向于频繁复发。 目的:综述关于治疗经典性固醇类靶器官和非靶器官的恶性肿瘤性不孕的累积数据。 方法:系统汇编相关文献。 结果与讨论:与大家普遍认知相反,不孕不育的治疗与恶性肿瘤的增长几乎无关。
关键词: 不孕不育,恶性肿瘤,促性腺激素,克罗米芬,流行病学,恶性肿瘤的风险
Current Medicinal Chemistry
Title:The Possible Role of Infertility Drugs in Later Malignancy: A Review
Volume: 23 Issue: 9
Author(s): Moshe Schaffer, Pamela Manuela Schaffer, Riad Kassem, Izhar Ben Shlomo
Affiliation:
关键词: 不孕不育,恶性肿瘤,促性腺激素,克罗米芬,流行病学,恶性肿瘤的风险
摘要: Background: Some 15% of all couples in the industrialized world suffer from infertility. Accordingly, any possible life-long morbidity that may result from treatments for infertility presents a significant concern to public health. The use of medications for infertility is specifically relevant to their possible effects on the classical target tissues for hormones involved in the sex axes, i.e., uterus, ovaries, and breast, but may have an effect on other organs, which harbor receptors for some of the hormones involved in reproduction. When one deals with the effect of treatment for infertility on the occurrence of malignant conditions, there is no doubt that certain malignancies tend to occur more frequently in women who suffered from and/or were treated for infertility. Objective: To review the accumulated data on the association of treatments for infertility with subsequent malignancies both in the classical target organs of sex steroids and in non-target organs. Methods: Systematic compilation of the relevant literature. Results & Conclusion: Contrary to popular believes, treatment for infertility is associated with very little increase in malignacies.
Export Options
About this article
Cite this article as:
Moshe Schaffer, Pamela Manuela Schaffer, Riad Kassem, Izhar Ben Shlomo , The Possible Role of Infertility Drugs in Later Malignancy: A Review, Current Medicinal Chemistry 2016; 23 (9) . https://dx.doi.org/10.2174/0929867323666160217123443
DOI https://dx.doi.org/10.2174/0929867323666160217123443 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Current Protein & Peptide Science Pre-therapy Iodine-131 Uptake Value as a Prediction Method for Metastatic Lymph Node Status in Patients with Differentiated Thyroid Carcinoma
Current Medical Imaging P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Current Cancer Drug Targets Photosensitizers Mediated Photodynamic Inactivation Against Virus Particles
Mini-Reviews in Medicinal Chemistry Chemical Constituents and Bioactivities of the Plants of Genus Flemingia Roxb. et Ait. (Leguminosae)
Combinatorial Chemistry & High Throughput Screening A Computer-Based Approach to the Rational Discovery of New Trichomonacidal Drugs by Atom-Type Linear Indices
Current Drug Discovery Technologies Recent Developments of Flavonoids with Various Activities
Current Topics in Medicinal Chemistry Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
Current Medicinal Chemistry The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Lessons from Viruses: Controlling the Function of Transmembrane Proteins by Interfering Transmembrane Helices
Current Medicinal Chemistry Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
Current Pharmaceutical Biotechnology The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Recent Advances of Metal Binding Protein Lactoferrin as an Anti- Microbial Agent
Current Bioactive Compounds Preclinical Evaluation of In-111 and Ga-68 Labelled Minigastrin Analogues for CCK-2 Receptor Imaging
Current Radiopharmaceuticals Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
Current Cancer Drug Targets Hepatocyte FRS2α is Essential for the Endocrine Fibroblast Growth Factor to Limit the Amplitude of Bile Acid Production Induced by Prandial Activity
Current Molecular Medicine Patented Biomarkers of Peripheral Blood for the Early Detection of Cancer
Recent Patents on Biomarkers Interactions of Metal Ions with DNA, Its Constituents and Derivatives, which may be Relevant for Anticancer Research
Current Topics in Medicinal Chemistry Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Current Pharmaceutical Design Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets